Markets:

Overview

News

Currencies

International

Treasuries

BioNTech SE - American Depositary Shares (NQ:BNTX)

94.71 +1.69 (+1.82%)

Streaming Delayed Price Updated: 1:36 PM EDT, May 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BioNTech SE - American Depositary Shares

< Previous 1 2

...

21 22 23 24 25 26 27 28 29

...

72 73 Next >

BioNTech Announces New ADS Repurchase Program

March 28, 2023

From BioNTech SE

Via GlobeNewswire

Why Shares of BioNTech Slumped Monday ↗

March 27, 2023

The company released fourth-quarter earnings.

Via The Motley Fool

Elon Musk-Led Neuralink Seeks Human Trial Collaborators, Credit Suisse May Face Disciplinary Action, First Citizens Takeover Silicon Valley Bank: Today's Top Stories ↗

March 27, 2023

Benzinga

Via Benzinga

BioNTech, Coinbase Global, Pharming Group And Other Big Stocks Moving Lower On Monday ↗

March 27, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Monday. Here are some big stocks recording losses in today’s session.

Via Benzinga

BioNTech Earnings Preview ↗

March 24, 2023

Via Benzinga

4 Analysts Have This to Say About BioNTech ↗

March 23, 2023

Via Benzinga

Price Over Earnings Overview: BioNTech ↗

March 20, 2023

Via Benzinga

BioNTech Is Ripe For A Rebound In 2023

March 27, 2023

BioNTech had a strong quarter and may become a takeover target due to its healthy pipeline and a looming patent cliff for big pharma.

Via MarketBeat

Topics Intellectual Property

BioNTech Stock Crumbles After 2023 Outlook Misses By Almost $3 Billion ↗

March 27, 2023

For the year, BioNTech said it expects about $5.4 billion in sales of its Covid shot.

Via Investor's Business Daily

Why BioNTech Shares Are Trading Lower Today ↗

March 27, 2023

BioNTech SE (NASDAQ: BNTX) shares are falling in the premarket session today after the company reported Q4 earnings and expected lower annual revenue from the Covid-19 vaccine.

Via Benzinga

Earnings Scheduled For March 27, 2023 ↗

March 27, 2023

Companies Reporting Before The Bell • Viomi Technology Co (NASDAQ:VIOT) is likely to report earnings for its fourth quarter. • Vislink Technologies (NASDAQ:VISL) is projected to report earnings for its...

Via Benzinga

BioNTech Q4 2022 Earnings Conference Call On March 27, 2023 At 08:00 AM ET ↗

March 16, 2023

Via Benzinga

US Stocks Poised To Start New Trading Week Higher On Hopes Of Resolving Banking Crisis: Analyst Warns 'No News Would Be Good News' ↗

March 27, 2023

The recent positive momentum seen in the market could carry over into the new week, as indicated by the index futures, which were holding up early Monday.

Via Benzinga

BioNTech Announces Fourth Quarter and Full Year 2022 Financial Results and Corporate Update

March 27, 2023

From BioNTech SE

Via GlobeNewswire

Could CRISPR Therapeutics Become the Next Moderna? ↗

March 27, 2023

Both companies use cutting-edge technology.

Via The Motley Fool

Carnival, BioNTech And 3 Stocks To Watch Heading Into Monday ↗

March 27, 2023

With US futures trading mixed this morning on Monday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

Investor Fear Increases Amid Recent Bank Concerns ↗

March 27, 2023

The CNN Money Fear and Greed index showed some increase in the fear level among U.S. investors. US stocks closed higher on Friday following a volatile trading session. All the major indices recorded...

Via Benzinga

7 Blue-Chip Stocks Sitting in the Sweet Spot ↗

March 23, 2023

Although blue-chip stocks carry a reputation for being bulky and not exciting, these large enterprises can really move.

Via InvestorPlace

China's First mRNA Vaccine: Drugmaker CSPC Wins China's Approval For COVID-19 Vaccine ↗

March 22, 2023

Chinese health authorities approved CSPC Pharmaceuticals Group Ltd's (OTC: CSPCY) messenger RNA (mRNA) COVID-19 vaccine for emergency use authorization.

Via Benzinga

Additional COVID-19 Booster Shots? Officials Anticipate FDA Authorization Within Few Weeks ↗

March 21, 2023

The U.S. Food and Drug Administration is reportedly moving toward authorizing a second round of omicron-targeted COVID-19 booster shots for the elderly and other people at high risk.

Via Benzinga

Covid Vaccine Battle Brewing: Moderna's Stephane Bancel Vs. Bernie Sanders ↗

March 21, 2023

Moderna CEO Stephane Bancel will face a Senate Committee over pricing plans.

Via Investor's Business Daily

Where Did COVID-19 Really Originate? Biden Signs Bill To Declassify Origins Information ↗

March 21, 2023

Via Benzinga

Moderna Wants To Charge About $130 Per COVID-19 Vaccine Dose ↗

March 21, 2023

From now on, Moderna Inc (NASDAQ: MRNA) expects to charge $130 per dose for its COVID-19 vaccine as purchases move from the government to the private sector.

Via Benzinga

BioNTech and OncoC4 Announce Strategic Collaboration to Co-Develop and Commercialize Novel Checkpoint Antibody in Multiple Solid Tumor Indications

March 20, 2023

From BioNTech SE

Via GlobeNewswire

7 Stocks Set to Soar When the Market Recovers ↗

March 16, 2023

Daring contrarians can bid up the danger with these intriguing market ideas.

Via InvestorPlace

FDA Approves Pfizer/BioNTech's Bivalent COVID-19 Vaccine For Youngest Kids ↗

March 15, 2023

Via Benzinga

Did Elon Musk Just Put His Skepticism Behind And Warm Up To mRNA Tech That Powers Most COVID-19 Vaccines? ↗

March 14, 2023

Tesla CEO Elon Musk has been a skeptic of the COVID-19 vaccines and highly critical of Dr.

Via Benzinga

BioNTech to Report Full Year and Fourth Quarter 2022 Financial Results and Operational Update on March 27, 2023

March 13, 2023

From BioNTech SE

Via GlobeNewswire

Wall Street Thinks These 2 Undervalued Stocks Have Exceptional Growth Potential ↗

March 10, 2023

They're both facing the same fierce headwind, and it won't be going away soon.

Via The Motley Fool

How Much Did US Government Spend On mRNA Vaccine Technology Before And During The Pandemic? The Number Can Be Surprising ↗

March 03, 2023

Via Benzinga

< Previous 1 2

...

21 22 23 24 25 26 27 28 29

...

72 73 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.